جستجوی مقالات مرتبط با کلیدواژه « pulmonary rehabilitation » در نشریات گروه « پزشکی »

Patients with severe COVID‑19 suffer from various problems such as impaired lung function, decreased exercise capacity, mental disorders, and reduced quality of life. This study aimed to evaluate the effectiveness of short‑term pulmonary rehabilitation in patients recovering from severe COVID‑19.

The present study was a retrospective cohort study. This study was conducted in 2021 on 92 patients with severe COVID‑19 who met the inclusion criteria. Inter‑professional pulmonary rehabilitation sessions were performed for 3 weeks, twice a week (six sessions in total), for this group of patients, which included physical exercises, educational activities, and other health‑related services (counseling and psychotherapy). Outcomes assessed included a 6‑min walk test, the score of the Hospital Anxiety and Depression Scale, and the SF‑12 Quality of Life Questionnaire, which were completed before and after pulmonary rehabilitation. Data analysis was performed using analytical and descriptive statistics.

The statistical analyses showed that 60.86% of patients participating in the study were male and 39.14% were female, and the mean age of patients was 54.9 ± 12.3 years. The findings also showed that the average distance traveled in the 6‑min walk test before pulmonary rehabilitation was 289.2174 ± 130.5 m; however, after the intervention, this rate reached 343.0870 ± 103.5 m, which demonstrated a statistically significant difference (P = 0.00). Also, significant changes were observed in anxiety and depression, the ability to perform daily activities, and the physical health of patients before and after the intervention (P < 0.05).

Short‑term pulmonary rehabilitation is a safe and useful treatment without side effects that can be effective in reducing anxiety and depression, increasing the ability to perform daily activities and exercise capacity, and consequently, improving the quality of life of patients recovering from severe COVID‑19.

Pneumoconiosis is a collection of lung diseases caused by inhaling mineral dust that poses an important risk to public health worldwide. Effective clinical treatments are currently limited, but pulmonary rehabilitation (PR) has shown promise in treating respiratory diseases. This review aims to assess the effectiveness of PR strategies for treating pneumoconiosis. We searched research studies that investigated the effectiveness of PR interventions for pneumoconiosis patients in international scientific databases and comprehensively reviewed PR strategies for the treatment of pneumoconiosis. Pneumoconiosis patients are increasingly being treated with a multimodal PR program. PR interventions could save healthcare costs, reduce dyspnea, improve exercise performance, and enhance overall health-related quality of life in patients with pneumoconiosis. PR interventions are effective in improving respiratory function and quality of life in patients with pneumoconiosis. However, further research is needed to determine the optimal PR strategies for pneumoconiosis patients and to investigate the long-term effects of these interventions.

Inspiratory muscle training has been introduced as one of the effective methods in pulmonary rehabilitation, and attention to this technique in patients with COVID-19 is still being studied. In the present study 52 patients who have undergone the period of the COVID-19 disease were randomly divided into two groups. In the control group, in addition to the routine treatment prescribed by a specialist physician, rehabilitation was performed by performing diaphragmatic breathing exercises, pursed-lips breathing, chest expansion, and simple stretching exercises. In the intervention group in addition to the rehabilitation program provided to the control group, patients used an inspiratory muscle training device. This pulmonary rehabilitation program was performed twice a day and 30 repetitions each time with a two-minute rest after every 10 exercises. After 4 weeks, patients in both groups were referred to the hospital for re-assessment of the distance of the 6-minute walk test, SF-12 questionnaire results, dyspnea, and S-index. To compare quantitative variables between the two groups we utilized a student t-test. Type one error was put at P≤0.05. The comparison of 6MWT values shows that the mean of this index in the intervention group is significantly higher than the control group (p = 0.002). Also, the S-index of the two groups showed a significant difference (p=0.024). Results show a significant increase in the SF-12 quality of life questionnaire in patients using IMT (p=0.001). IMT improves pulmonary functions, 6MWT, and SF-12 Questionnaire in recovered COVID-19 patients.

Idiopathic pulmonary fibrosis (IPF) is characterized by progressively worsening lung function, ventilation capacity, dyspnea, and finally reduced exercise intolerance. All of these have a significant negative impact on functional capacity and quality of life. In this study, we aim to evaluate the effects of pulmonary rehabilitation (PR) in IPF and assess the predictors of success.

Data from 17 IPF patients who completed the program from the total of 27 patients who applied to PR were used in our study. We evaluated their pulmonary function tests, exercise capacity, peripheral-respiratory muscle strength, body composition, quality of life, and psychological states before and after PR.

Following the PR program, improvements over the minimal clinically important differences were observed in almost all parameters compared to the baseline; however, statistically significant improvements were only observed in the medical research council (P=0.020), the St. George respiratory questionnaire (P=0.002), the maximal inspiratory pressure (P=0.024), the anxiety score (P=0.001), the depression score (P=0.002), and the right quadriceps muscle strength (P=0.046). There was only a statistically significant negative correlation between the initial forced vital capacity and the forced expiratory volume in one-second value with the increase in patients’ maximal inspiratory pressure values after PR. 

After a multidisciplinary, comprehensive PR program, dyspnea sensation, exercise capacity, endurance time, quality of life, respiratory and peripheral muscle strengths, and psychological status were improved regardless of age, gender, antifibrotic treatment, and comorbidities. Therefore, patients should be referred to PR units before the deterioration in the quality of life in the early stages of the disease.

Respiratory failure caused by pneumonia is the leading cause of death in coronavirus disease 2019 (COVID-19) patients; furthermore, anxiety and depression caused by this disease and its complications, as the most common psychological disorders might harm the mental health of COVID-19 patients.

This study aimed to look into the effect of a home-based pulmonary rehabilitation (HBPR) program on anxiety and depression in COVID-19 patients (severe acute respiratory syndrome).

This randomized clinical trial was conducted on 70 COVID-19 patients in Kerman, Iran, in 2021, randomly allocated into 2 equal groups of control (n = 35) and intervention (n = 35). In the control group, the patients received only routine post-discharge care, and in the intervention group, the patients received HBPR procedures based on the “Guide to Restoring Movement COVID-19 Protocol” by John Hopkins University, the United States, that teaches to patients after discharge. The Hospital AnxietyandDepression Scale was used to determine anxiety and depression status and scores before and after 4-week procedures. Additionally, the chisquare, Fisher’s exact, and Mann-Whitney U tests were used to compare anxiety and depression status and scores between the 2 groups. P < 0.05 was considered statistically significant.

The median score of anxiety (5 vs. 14, P < 0.0001) and depression (6 vs. 10, P < 0.0001), 4 weeks after discharge from the hospital in the intervention group, was significantly lower than in the control group based on the Mann-WhitneyUtest (P< 0.0001).

This rehabilitation procedure is effective in the reduction of anxiety and depression in COVID-19 patients and their pulmonary status. Therefore, it can be used as a treatment procedure for mental recovery in these patients.

Dyspnea and decreased O2 saturation are the most common causes of hospitalization in noncritical COVID-19 patients. Breathing exercises and chest physiotherapy are used for managing the patients. These treatments are, however, not well supported by scientific evidence. In a randomized controlled trial, 80 patients were randomly assigned to planned breathing exercises (n=40) and control groups (n=40). The participants in the intervention group were instructed to blow into a balloon five times a day while lying down. Other therapies were similar in both groups. The severity of dyspnea at rest/after activity and peripheral oxygen saturation (SpO2) with/without O2 therapy were compared between the two groups on the first, second, and third days. The study findings showed no statistically significant difference in SpO2 with/without O2 therapy on the first, second, and third days between the two groups. Although the severity of dyspnea showed no significant difference between the two groups, the mean score of dyspnea at rest (2.72±2.25 vs. 1.6±1.21, P=0.007) and after activity (4.53±2.04 vs. 3.52±1.66, P=0.017) improved in the intervention group on the third day. Balloon-blowing exercise improves dyspnea in noncritical Covid-19 patients, but it does not significantly improve oxygenation.

The acute nature and complications of COVID-19, including fatigue and dyspnea, reduce the ability of the affected individuals to play individual and social roles and perform activities of daily living, and have adverse effects on the life quality and economic status of patients. Conducting pre-discharge rehabilitation programs following a home-based approach can be effective in reducing fatigue and dyspnea and improving the activities of daily living of COVID-19 patients.

This study aimed to investigate the effect of home-based pulmonary rehabilitation on fatigue, dyspnea, and activities of daily living of COVID-19 patients in the teaching hospitals of Zahedan University of Medical Sciences in 2020.

The quasi-experimental study enrolled 60 patients with COVID-19 respiratory symptoms admitted to the COVID-19 intensive care units of teaching hospitals affiliated with Zahedan University of Medical Sciences in 2020. The patients who met the inclusion criteria were selected using convenience sampling and randomly divided into intervention and control groups with color cards. The instruments used to collect the data were the Fatigue Severity Scale (FSS), the Borg Dyspnea Scale, and the Barthel Index completed by the participants before, two weeks, and two months after the intervention. The rehabilitation training was provided to the patient and the primary caregiver in the intervention group in three 45-min sessions individually and using training videos during the hospital stay. After discharge, the patients were followed up in person or by phone for eight weeks to ensure the effectiveness of the rehabilitation program. The collected data were analyzed using SPSS-22 software through repeated measures analysis of variance (ANOVA), independent samples t-test, and chi-square test at a significance level of 0.05 (P < 0.05).

The repeated measures ANOVA showed that changes in the fatigue and dyspnea scores were significant over time (P < 0.001). Furthermore, the intervention effect was significant (P = 0.04), and more remarkable changes were observed in the intervention group than in the control group. Given the significance of the group-time interactive effect on the two given variables, the comparisons were made point by point and with Bonferroni correction again by time and group. There were significant differences in the mean fatigue scores in the second (P = 0.03) and third (P < 0.001) stages and the mean dyspnea scores (P < 0.001) between the two groups. The mean scores of activities of daily living two weeks and two months after the intervention were significantly different between the two groups, with higher scores in the intervention group than in the control group (P = 0.01). The repeated measures ANOVA confirmed a statistically significant difference between the two groups in terms of the effect of time (P < 0.001) and group (P = 0.03) on the patients’ activities of daily living.

The study showed that home-based pulmonary rehabilitation measures were effective on fatigue, dyspnea, and activities of daily living of COVID-19 patients. Thus, this intervention approach by nurses for family participation can be practical for treating acute and chronic respiratory diseases.

Chronic Obstructive Pulmonary Disease (COPD) impairs patients` quality of life and clinical outcomes. Pulmonary rehabilitation (PR) program can improve the functional capacity in patients with chronic lung disease. Thus, the study aimed to evaluate the effect of the PR program on the quality of life, anxiety, depression, and pulmonary function of patients with COPD.

In this single-group before-and-after clinical trial, adult patients with COPD and recent history of exacerbation were recruited. The intervention was a PR program, including training of breathing exercises at home and aerobic exercise program, twice a week about 30 to 60 min for 8 weeks. The program was prepared according to the patient’s tolerance by a sports medicine specialist in a pulmonary rehabilitation clinic. The primary outcome was quality of life measured by the St. George’s Respiratory Questionnaire (SGRQ). Secondary outcomes were assessing anxiety, depression, pulmonary function, COPD status, the ability to walk, and shortness of breathing. All outcomes were measured before and one week after the program.

Twenty-two eligible patients of both genders (68% male and 32% female) with a Mean±SD age of 65.09±9.72 years finished the program. Quality of life was improved significantly following the intervention (51.49 [16.68] vs 4275 [15.63]; P<0.001]. Anxiety and depression (P<0.001), pulmonary function parameters, such as forced expiratory volume in 1 second (FEV1) (P<0.001) and FEV1/ forced vital capacity (FVC) ratio (P=0.015), COPD status (P=0.001), the ability of walk1ing (P<0.05), and shortness of breath (P=0.001) were improved significantly after the intervention.

The PR program resulted in clinical improvement in patients with COPD. Thus, we recommend that it be used besides medical management.

Chronic Obstructive Pulmonary Disease (COPD) leads to limited activity and reduced quality of life. Treatment of this disease is a long-term process that requires the cooperation of patients in monitoring and treatment. In the present study which was conducted from April 2019 to March 2021 in Masih Daneshvari Hospital, Tehran, Iran, 75 patients were randomly divided into telerehabilitation and control groups. Patients in the control group received pulmonary rehabilitation including respiratory, isometric, and aerobic exercises for 8 weeks, three times per week. In the second group, patients were given a lung rehabilitation booklet and asked to repeat the exercises three times a week for four weeks according to a specific schedule. In addition, patients installed Behzee care application on the mobile phone that recorded various indicators such as heart rate, SpO2, dyspnea, fatigue, and daily activities. This application reminded the patient of the program every day and at a specific time. Finally, the patients’ conditions were compared in the two groups after 8 weeks using CAT and mMRC questionnaires and 6-Minute Walk (6MW) exercise indices as well as spirometry tests.  In all four indicators (6MW, CAT,  and mMRC questionnaires as well as spirometry), patients showed improvement after rehabilitation (p<0.001). This improvement was significantly higher in the telemedicine group compared to the other group (p<0.01). The use of telerehabilitation in COPD patients is effective in improving spirometry indices, quality of life, as well as activity and sports indices.

At the end of 2019, Severe Acute Respiratory Syndrome (SARS) of coronavirus 2SARS-CoV-2) emerged in Wuhan, Hubei Province, China, and infected over 16 million people around the world. Individuals with coronavirus disease 2019 (COVID-19) have an influenza-like illness and respiratory tract infections. We can categorize patients in three main groups: asymptomatic infected cases, patients with mild upper respiratory tract illness, and patients with severe viral pneumonia with respiratory failure. According to reports, almost 80% of cases are asymptomatic or show mild symptoms, 15% have severe symptoms, and the other 5% are critical cases requiring ventilation and life support.

Chronic obstructive pulmonary disease (COPD) is a debilitating condition. Those with COPD often complain about fatigue, which can negatively affect activities of daily living, and consequently, the quality of life (QoL).

This study aimed at determining the effect of pulmonary rehabilitation on fatigue and QoL in patients with COPD.

This quasi-experimental study was performed on 40 eligible patients with COPD admitted to two teaching hospitals in Zahedan in 2018 - 2019. The subjects were randomized into the experimental (n = 20) and control (n = 20) groups based on convenience sampling. Data collection tools included a demographic questionnaire, St George’s Respiratory questionnaire (SGRQ), and the Multidimensional Fatigue inventory (MFI). The QoL and fatigue in both groups were initially measured through interviews. For three consecutive days, patients in the experimental group received three 30-45-min face-to-face training sessions. The pulmonary rehabilitation program was conducted on patients’ bedsides and included theoretical and practical dimensions. Additionally, after necessary coordination with the patients and their families, a summary session was held at patients’ homes. The control group received no training, except for routine care. At the end of the eighth week, the researchers made telephone contact with the two groups (patients or their families) and visited them at their home to complete the SGRQ and MFI. Data were analyzed using SPSS and descriptive and analytical tests (independent t-test, paired t-test, and chi-squared test) at the significance level of less than 0.05.

The mean score of changes in QoL was 21.75 ± 7.06 in the experimental group and -1.93 ± 4.70 in the control group. The results of the paired t-test indicated that the mean score of QoL in the experimental group in the post-test was significantly different compared with the baseline (P = 0.001). Moreover, the mean score of changes in fatigue was 35.65 ± 7.12 in the experimental group and 3.25 ± 144 in the control group. In this regard, the paired t-test results showed that the mean fatigue score of patients in the experimental group in the post-test was significantly different compared with the baseline (P = 0.001).

Pulmonary rehabilitation program reduced fatigue and improved QoL in patients with COPD. Therefore, it is suggested to consider this program in the care plan of these people.

Dyspnea, shortness of breath, and inability to perform activities of daily living are the main complaints in patients with COVID-19 and physiotherapy has a vital role in managing such symptoms. We present a case treated with pulmonary and neurological physiotherapy, which improved symptoms and quality of life. In this case report, the importance and potential effect of concise physiotherapy on patients with COVID-19 is presented.

Background and Despite the high prevalence of chronic obstructive pulmonary disease, There haven,t been definite curative treatment for the disease and focus of treatment has directed towards pulmonary rehabilitation as an effective non-drug treatments. this study were performed to determine the effect of motivational abdominal breathing device on breathing pattern and dyspnea of chronic obstructive pulmonary disease
This study is a clinical trial done in 2015 on 70 patients with chronic obstructive pulmonary disease admitted to Samen alaeme hospital, CHENARAN city. Patients were assigned to two groups of 35 persons, Intervention and control. groups did exercises at home twice a day for two weeks. The dyspnea, respiratory rate and depth of breathing, before, seventh day and after the intervention was measured by spirometry and dyspnea NRS scale. Data analysis was performed by SPSS version 11.5 using t-test, Mann-Whitney and repeated measures analysis.
The results showed that difference in respiratory rate before and after intervention (P=0/78) did not change significantly between two groups. But difference before and after the intervention, depth of breathing and before and after intervention of dyspnea were significantly changed in both groups (P The results of this study showed that motivational abdominal breathing device has a more positive effect than the abdominal breathing normally on respiratory status and thus can be used as effective rehabilitation techniques.

Generally ICU patients are in critical status and need long stay in ICU. Pulmonary rehabilitation program (PRP) is considered as an important tool to improve outcome and shorten the length of stay in ICU. The aim of this study was to investigate whether PRP can affect outcome and duration of hospitalization in ICU patients. This study was performed in medical ICU of Labafi Nejad hospital, Tehran, Iran during 2012 and 2013. All of patients who had more than one day stay in ICU were included in the study. They underwent PRP. We compared length of stay, mortality rate and number of hospitalized patients within 2 years in patients with PRP and patients without PRP. In 2012, 155 patients and in 2013, 173 patients were admitted in ICU. Admission period was 15 ± 2.7 and 11 ± 2.1 days, respectively (p< 0.001). Pulmonary physiotherapy showed no effect on patients’ outcome in which during 2012, 94 patients were discharged and 61 patients were died and in 2013, 98 patients were discharged and 64 patients were died (p=0.9). Our study shows that PRP can shorten hospitalization time which can indirectly decrease hospitalization costs but there is no effect on overall survival.

Chronic obstructive pulmonary disease (COPD) is one of the few major causes of death whose prevalence is continuing to rise in the world. Pulmonary rehabilitation (PR), as a component of the treatment protocol, should be considered for all patients with chronic respiratory disease who have persistent symptoms. The purpose of the study was to investigate PR in patients with COPD, following six questions including comprehensive definition, nature's mechanism, commencing indication, advantages and disadvantages, comprehensive dimensions, and the cornerstone dimension of PR. The University of York Center for Reviewers and Dissemination Guidance approach was used for searching seven databases (Science Direct, Ovid, Cochrane, Ebsco Host, Scopus, Pub Med, and SID) with nineteen keywords and different combinations of aforesaid nineteen keywords from the year 1985 to the January 2015. Thirty full texts met the inclusion criteria and were analyzed for responding to the six research questions. The results showed that PR consists of exercise training, education, nutritional intervention, support in self-management behaviors, and psychosocial support. The extensive review of the literature indicated exercise training is the cornerstone of PR, but the study also corroborated that psychological aspect of the patients with COPD is the most important and the first dimension in PR. Furthermore, before the commencing any education, the patients with COPD in any stages, must have an effective and useful psychological support for ameliorating and improving the applicability of the PR.